HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jean Sibilia Selected Research

Antisynthetase syndrome

1/2018Inflammatory myopathies: A new landscape.
7/2015Myocarditis in Patients With Antisynthetase Syndrome: Prevalence, Presentation, and Outcomes.
11/2013Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival.
12/2012Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jean Sibilia Research Topics

Disease

78Rheumatoid Arthritis
09/2023 - 02/2002
24Inflammation (Inflammations)
09/2023 - 03/2003
22Arthritis (Polyarthritis)
10/2022 - 07/2002
16Autoimmune Diseases (Autoimmune Disease)
01/2023 - 12/2002
14Myositis (Idiopathic Inflammatory Myopathies)
01/2022 - 12/2006
14Infections
12/2021 - 04/2004
13Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 01/2005
13Systemic Scleroderma (Systemic Sclerosis)
02/2020 - 12/2002
11COVID-19
11/2022 - 01/2020
11Fatigue
01/2022 - 01/2009
10Necrosis
11/2022 - 06/2004
10Pain (Aches)
01/2020 - 04/2002
9Neoplasms (Cancer)
01/2020 - 01/2005
6Joint Diseases (Joint Disease)
09/2021 - 07/2002
6Muscular Diseases (Myopathy)
01/2018 - 10/2010
5Rheumatic Diseases (Rheumatism)
10/2021 - 02/2008
5Osteoarthritis
09/2021 - 06/2004
5Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
12/2018 - 03/2003
4Vasculitis (Vasculitides)
02/2020 - 09/2011
4Dermatomyositis (Dermatopolymyositis)
01/2019 - 07/2011
4Antisynthetase syndrome
01/2018 - 12/2012
4Juvenile Arthritis (Juvenile Idiopathic Arthritis)
09/2015 - 04/2003
4Ulcer
02/2008 - 11/2003
3Proteinuria
01/2023 - 07/2003
3Reactive Arthritis (Reiter Disease)
09/2021 - 01/2008
3Takayasu Arteritis (Arteritis, Takayasu's)
10/2020 - 05/2012
3Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
10/2020 - 01/2018
3Pneumonia (Pneumonitis)
01/2020 - 04/2002
3Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2020 - 01/2011
3Synovitis
01/2019 - 12/2005
3Neutropenia
09/2017 - 04/2002
3Sepsis (Septicemia)
09/2017 - 08/2002
3Agranulocytosis (Granulocytopenia)
01/2017 - 04/2002
3Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2015 - 03/2011
3Myocardial Infarction
09/2006 - 03/2004
3Hemorrhage
04/2004 - 11/2003
2Lymphoma (Lymphomas)
10/2023 - 06/2002
2Psoriatic Arthritis
09/2021 - 05/2011
2Glomerulonephritis
02/2020 - 01/2019
2Multiple Sclerosis
01/2020 - 03/2012

Drug/Important Bio-Agent (IBA)

33Rituximab (Mabthera)FDA Link
10/2020 - 10/2008
18Methotrexate (Mexate)FDA LinkGeneric
01/2023 - 06/2002
18AntibodiesIBA
01/2022 - 01/2006
17Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2017 - 07/2003
15tocilizumab (atlizumab)FDA Link
05/2021 - 06/2010
14Abatacept (Orencia)FDA Link
11/2022 - 08/2005
13Antirheumatic Agents (DMARD)IBA
01/2020 - 07/2006
13AutoantibodiesIBA
10/2019 - 03/2003
11Proteins (Proteins, Gene)FDA Link
01/2023 - 07/2003
10CytokinesIBA
10/2022 - 06/2004
9Infliximab (Remicade)FDA Link
10/2020 - 07/2003
8GlucocorticoidsIBA
10/2021 - 07/2006
8Biomarkers (Surrogate Marker)IBA
09/2021 - 04/2011
8Etanercept (Enbrel)FDA Link
07/2014 - 04/2003
7B-Cell Activating FactorIBA
11/2022 - 01/2006
7Interleukin-6 (Interleukin 6)IBA
01/2020 - 07/2003
7ametantrone (HAQ)IBA
01/2019 - 11/2003
6AntigensIBA
01/2023 - 11/2004
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2020 - 11/2003
5Immunoglobulin G (IgG)IBA
01/2023 - 03/2003
5Adrenal Cortex Hormones (Corticosteroids)IBA
11/2022 - 03/2003
5Hydroxychloroquine (Plaquenil)FDA LinkGeneric
02/2022 - 07/2014
5Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 08/2002
5Rheumatoid FactorIBA
10/2013 - 08/2003
4VaccinesIBA
10/2022 - 06/2017
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10/2020 - 10/2013
4DNA (Deoxyribonucleic Acid)IBA
01/2020 - 12/2006
4InterferonsIBA
01/2020 - 05/2010
4Tumor Necrosis Factor InhibitorsIBA
09/2019 - 12/2012
4Reactive Oxygen Species (Oxygen Radicals)IBA
10/2017 - 06/2013
4SteroidsIBA
06/2017 - 07/2002
4Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
09/2015 - 09/2006
4Peptides (Polypeptides)IBA
05/2015 - 11/2004
4Monoclonal AntibodiesIBA
05/2015 - 10/2008
4Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA
11/2013 - 12/2006
3LigandsIBA
10/2023 - 01/2005
3micaIBA
09/2021 - 06/2007
3Imiquimod (Aldara)FDA LinkGeneric
01/2020 - 01/2016
3Immunosuppressive Agents (Immunosuppressants)IBA
01/2020 - 04/2015
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2017 - 04/2002
3C-Reactive ProteinIBA
12/2016 - 11/2003
3Ligases (Synthetase)IBA
07/2015 - 12/2006
3Adalimumab (Humira)FDA Link
07/2014 - 11/2009
3cyclic citrullinated peptideIBA
10/2013 - 01/2006
3Antinuclear AntibodiesIBA
03/2010 - 01/2005
2Intravenous Immunoglobulins (IVIG)FDA Link
01/2023 - 09/2011
2anti-dsDNA autoantibodyIBA
01/2023 - 01/2019
2InterleukinsIBA
11/2022 - 06/2004
2Prostaglandins AIBA
01/2022 - 08/2010
2Estrogens (Estrogen)FDA Link
01/2022 - 01/2021
2COVID-19 VaccinesIBA
12/2021 - 10/2021
2Calcium PyrophosphateIBA
09/2021 - 03/2013
2Uric Acid (Urate)IBA
09/2021 - 01/2020
2CholesterolIBA
05/2021 - 07/2006
2rheinIBA
01/2021 - 01/2019
2Antimalarials (Antimalarial Agents)IBA
01/2021 - 08/2018
2Vitamin DFDA LinkGeneric
01/2020 - 11/2018

Therapy/Procedure

42Therapeutics
11/2022 - 02/2002
8Biological Therapy
01/2019 - 12/2005
3Contraindications
03/2012 - 07/2006